Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
53.97B | 45.67B | 38.90B | 35.96B | 35.14B | Gross Profit |
47.54B | 40.10B | 34.44B | 32.00B | 31.09B | EBIT |
8.27B | 7.28B | 6.32B | 5.47B | 4.93B | EBITDA |
13.27B | 10.18B | 8.80B | 7.66B | 6.96B | Net Income Common Stockholders |
7.23B | 6.41B | 5.41B | 4.80B | 4.76B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
18.24B | 16.96B | 14.64B | 10.54B | 11.09B | Total Assets |
72.47B | 65.10B | 56.59B | 49.44B | 51.00B | Total Debt |
6.43B | 8.33B | 10.37B | 13.52B | 18.00B | Net Debt |
-11.80B | -8.64B | -4.27B | 2.98B | 6.91B | Total Liabilities |
28.19B | 26.68B | 26.59B | 26.79B | 31.60B | Stockholders Equity |
44.28B | 38.42B | 29.99B | 22.66B | 19.40B |
Cash Flow | Free Cash Flow | |||
6.06B | 5.59B | 7.81B | 4.73B | 3.99B | Operating Cash Flow |
9.77B | 8.50B | 9.82B | 6.77B | 5.59B | Investing Cash Flow |
-3.74B | -3.76B | -2.08B | -1.78B | -2.13B | Financing Cash Flow |
-5.02B | -3.04B | -3.99B | -5.22B | -3.13B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | $510.42B | 25.04 | 34.91% | 1.86% | 15.40% | 30.51% | |
74 Outperform | ¥116.11B | 18.69 | 2.16% | 12.93% | -14.89% | ||
73 Outperform | $1.74T | 54.80 | 16.14% | 0.91% | -11.38% | -33.42% | |
69 Neutral | $11.95T | 33.30 | 19.56% | 0.29% | 4.09% | 13.88% | |
63 Neutral | ¥55.29B | 10.17 | 3.91% | -0.61% | -5.35% | ||
61 Neutral | ¥11.87B | 26.07 | 3.51% | -4.43% | -48.23% | ||
52 Neutral | $5.21B | 3.55 | -41.91% | 2.83% | 15.12% | 0.42% |